延長石油國際(00346.HK)預期年度扭虧為盈約3.58億港元
格隆匯3月7日丨延長石油國際(00346.HK)發佈公吿,公司預期截至2021年12月31日止年度將錄得盈利約3.58億港元,對比去年虧損約7.93億港元。
受惠於全球經濟從COVID-19大流行中復甦,以及石油需求旺盛和供應短缺導致油價大幅反彈,集團2021年實現扭虧為盈,主要綜合原因由於(i)加拿大油氣生產業務產生利潤約700萬港元;(ii)中國石油及副產品貿易業務產生合共淨利潤約4,100萬港元;(iii)集團油氣資產淨減值回撥約3.33億港元;以及(iv)集團應計行政及利息開支約2,300萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.